It is intended to provide a method of screening a remedy for human diabetes which comprises administering test compounds to nonhuman mammal diabetic models and selecting a compound causing a decrease in glycohemoglobin level of 0.5% or more after the administration.
申请公布号
WO03091728(A1)
申请公布日期
2003.11.06
申请号
WO2003JP05254
申请日期
2003.04.24
申请人
TAKEDA CHEMICAL INDUSTRIES, LTD.;KATO, KOKI;NAGISA, YASUTAKA;ODAKA, HIROYUKI
